Postdoctoral Researcher (f/div/m) Complement Genetics & Glomerular Diseases- Jena, Germany

The Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute – (Leibniz-HKI, www.leibniz-hki.de) investigates the pathobiology of human-pathogenic fungi and identifies targets for the development of novel natural product-based antibiotics.

The Department of Infection Biology invites talented and highly gifted candidates to apply as a

Postdoctoral Researcher (f/div/m) Complement Genetics & Glomerular Diseases

for two years initially.

Your profile:

  • Doctoral degree in biology, genetics or life sciences
  • Experience, knowledge and good experimental skills in molecular biology, genetics, biochemistry
  • Knowledge of complement and immunobiology, bioinformatics, cell biology and microbiology is an advantage

We offer:

The successful candidates will investigate the field of complement genetics, complement regulators and pathology of renal diseases. Main topics of the project are:

  • Identification of genetic mutations of complement genes in the renal diseases C3 glomerulopathy and atypical hemolytic uremic syndrome
  • Next generation sequencing for genetic diagnostics
  • Functional characterization of FHR2 and FHR5 proteins in complement system and beyond; for further details please see literature below

Salary is paid according to German TV-L (salary agreement for public service employees). As an equal opportunity employer, the Leibniz-HKI is committed to increasing the percentage of female scientists and therefore especially encourages them to apply.

Further information:

Prof. Dr. Peter Zipfel | +49 3641 532 1301 | career@leibniz-hki.de

Applications:

Complete applications in English should include a cover letter, a CV containing a complete list of publications, a brief statement of research experiences, the addresses of two possible referees, and should be submitted by September 30, 2020, via the Leibniz-HKI online application system.

Check Also

A Revolutionary Cancer Treatment Sets New Medical Milestones

A promising cancer treatment is set to change the face of traditional therapies. Imagine a …